Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) EBT (2016 - 2025)

Surgery Partners' EBT history spans 12 years, with the latest figure at $42.6 million for Q4 2025.

  • For Q4 2025, EBT fell 42.59% year-over-year to $42.6 million; the TTM value through Dec 2025 reached $116.9 million, down 20.53%, while the annual FY2025 figure was $116.9 million, 20.53% down from the prior year.
  • EBT for Q4 2025 was $42.6 million at Surgery Partners, up from $30.8 million in the prior quarter.
  • Across five years, EBT topped out at $74.2 million in Q4 2024 and bottomed at -$400000.0 in Q1 2023.
  • The 5-year median for EBT is $31.8 million (2023), against an average of $29.5 million.
  • The largest annual shift saw EBT skyrocketed 7275.0% in 2024 before it tumbled 101.05% in 2025.
  • A 5-year view of EBT shows it stood at $54.7 million in 2021, then tumbled by 39.31% to $33.2 million in 2022, then surged by 58.73% to $52.7 million in 2023, then skyrocketed by 40.8% to $74.2 million in 2024, then tumbled by 42.59% to $42.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's EBT are $42.6 million (Q4 2025), $30.8 million (Q3 2025), and $43.8 million (Q2 2025).